Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.6000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.5200/ 2
- Ask / Lots2.0000/ 8
- Open / Previous Close0.0000 / 1.6000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:38 ET | 618 | 1.6158 |
| 09:50 ET | 100 | 1.6671 |
| 09:54 ET | 100 | 1.6671 |
| 09:56 ET | 4000 | 1.6105 |
| 09:57 ET | 800 | 1.6304 |
| 09:59 ET | 1183 | 1.6102 |
| 10:01 ET | 11224 | 1.6 |
| 10:06 ET | 600 | 1.58 |
| 10:10 ET | 100 | 1.58 |
| 10:12 ET | 1346 | 1.5801 |
| 10:14 ET | 100 | 1.58 |
| 10:17 ET | 300 | 1.58 |
| 10:21 ET | 100 | 1.6 |
| 10:26 ET | 100 | 1.6 |
| 10:28 ET | 1300 | 1.6 |
| 10:32 ET | 100 | 1.6 |
| 10:33 ET | 100 | 1.6 |
| 10:37 ET | 600 | 1.6 |
| 10:39 ET | 100 | 1.58 |
| 10:44 ET | 100 | 1.58 |
| 10:46 ET | 100 | 1.58 |
| 10:50 ET | 100 | 1.59 |
| 10:51 ET | 100 | 1.59 |
| 10:55 ET | 400 | 1.59 |
| 10:57 ET | 100 | 1.59 |
| 11:02 ET | 100 | 1.58 |
| 11:04 ET | 100 | 1.58 |
| 11:08 ET | 200 | 1.58 |
| 11:11 ET | 100 | 1.58 |
| 11:15 ET | 100 | 1.59 |
| 11:18 ET | 100 | 1.59 |
| 11:22 ET | 100 | 1.59 |
| 11:24 ET | 100 | 1.595 |
| 11:26 ET | 200 | 1.595 |
| 11:29 ET | 600 | 1.59 |
| 11:31 ET | 3347 | 1.575 |
| 11:45 ET | 1000 | 1.5828 |
| 11:54 ET | 200 | 1.58 |
| 11:56 ET | 920 | 1.5899 |
| 12:05 ET | 891 | 1.58 |
| 12:18 ET | 8329 | 1.58 |
| 12:21 ET | 635 | 1.5971 |
| 12:34 ET | 8100 | 1.6 |
| 12:36 ET | 5698 | 1.5999 |
| 12:43 ET | 601 | 1.6 |
| 01:14 ET | 978 | 1.59 |
| 02:09 ET | 100 | 1.59 |
| 02:31 ET | 700 | 1.5879 |
| 02:36 ET | 2709 | 1.59 |
| 02:38 ET | 100 | 1.59 |
| 02:42 ET | 700 | 1.59 |
| 02:44 ET | 522 | 1.59 |
| 02:45 ET | 800 | 1.59 |
| 02:47 ET | 200 | 1.59 |
| 02:51 ET | 100 | 1.59 |
| 03:02 ET | 1700 | 1.59 |
| 03:03 ET | 100 | 1.59 |
| 03:07 ET | 10513 | 1.59 |
| 03:09 ET | 2748 | 1.59 |
| 03:12 ET | 100 | 1.5896 |
| 03:14 ET | 200 | 1.5899 |
| 03:16 ET | 716 | 1.5899 |
| 03:18 ET | 2307 | 1.59 |
| 03:23 ET | 200 | 1.59 |
| 03:25 ET | 4034 | 1.5999 |
| 03:34 ET | 2091 | 1.5999 |
| 03:36 ET | 2000 | 1.59 |
| 03:38 ET | 100 | 1.59 |
| 03:41 ET | 293 | 1.59 |
| 03:43 ET | 1905 | 1.59 |
| 03:45 ET | 500 | 1.58 |
| 03:48 ET | 270 | 1.59 |
| 03:54 ET | 400 | 1.59 |
| 03:57 ET | 332 | 1.5999 |
| 03:59 ET | 1600 | 1.6 |
Apr 17, 2024
Milestone(R) Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium, from 8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 8, 2024
Apr 3, 2024
Milestone(R) Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference, from 8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 85.0M | -1.2x | --- |
Barinthus Biotherapeutics PLC | 85.6M | -1.2x | --- |
Chimerix Inc | 84.7M | -1.0x | --- |
Provectus Biopharmaceuticals Inc | 81.8M | -26.4x | --- |
vTv Therapeutics Inc | 84.2M | -2.9x | --- |
Passage Bio Inc | 83.2M | -0.7x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer, Director
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $85.0M |
|---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 53.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.77 |
EPS | $-1.39 |
Book Value | $0.50 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 85.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,109.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
